Clinical Trial Search

Primary: Percentage of Participants Who Achieved a ≥ 4-point Reduction From Baseline in Dermatology Life Quality Index (DLQI) at Week 16 — 41.3; 73.3 percentage of participants…

Primary: Vision Scores — 57.48; 61.97 CLUE points

Primary: Measurement of the Proliferation Marker Ki67 (% Positive Tumor Cells) — -2.2; -4.1 log fold change in Ki67

Primary: Change in Plasma Cortisol Concentrations From Baseline — 36.62; 0.64; 6.26; 29.77 nmol/L

Primary: Zarit Burden Inventory (ZBI) Score — 37.34; 35.78; 35.94; 35.26 score on a scale

Primary: Glycemic Control — 10.8; 9.43; 9.4; 11.0 percent HbA1c

Primary: Percentage of Subjects With 1 or More Culture-Verified Acute VVC Episodes During the Maintenance Phase of the Study in the Intent-to-Treat Population — 6.7; 42.8…

Primary: Knowledge Assessed by Prostate Cancer Treatment Questionnaire — 0.69; 0.65; 0.58; 0.56 percentage of items correct

Primary: Tumor Response (Overall Response = Complete Response + Partial Response + Progressive Disease + Stable Disease) — 24; 22 participants

Primary: Pain Intensity Scores at 96 Hours at Rest Using Numerical Rating Scale (NRS) — 2.8; 2.0; 3.0; 2.8 score on a scale — p=0.2912

Primary: Confirmation of Prostate Cancer Recurrence by 68Ga-PSMA-11 PET/CT — 46; 15 Participants

Primary: Phosphorus Levels — 5.3; 5.6; 5.4; 6 mg/dL

Primary: Opioid Consumption Following Rotator Cuff Surgery — 31; 25; 25; 21 oral morphine mg equivalents (OME) — p=0.1771

Primary: The i) Percent Sensitivity and ii) Percent Specificity of Click Device for Detection of Chlamydia Trachomatis (CT) in Self-collected Vaginal Specimens as Compared to PIS…

Primary: Change in Ratio of Intratumoral Cytotoxic T Cells to Regulatory T Cells (CD8/Treg) — 8.6 no unit of ratios with same units(%) — p=0.109